National Immunization Awareness Month

by | Aug 10, 2021 | CDC, FDA, Healthcare, HIV, Immunization

National Immunization Awareness Month started this month! With back-to-school preparations and an increase in COVID-19, it is a good time to become knowledgeable about vaccines. This month is also a perfect opportunity to make sure children are properly vaccinated before they head back into the classroom.

Founded by the National Public Health Information Coalition in 2013, National Immunization Month is about highlighting the importance of vaccinations for all individuals of every age. Other objectives for National Immunization Month are to utilize media to reach audiences with tailored messages and resources, and to disseminate consistently, coordinated messages across the national, state, and local levels.

There is not a single preventive health measure more crucial than vaccination and immunization. According to the World Health Organization, the international medical community has strongly endorsed the usage of vaccines and immunizations to prevent and help control a variety of infectious diseases, like chickenpox, diphtheria, Human Papillomavirus, or HPV, and measles.

Individuals can observe National Immunization Awareness Month by checking in with their primary care physician about vaccination needs for their family, and to find out more about the importance of vaccinations and immunizations in their community.

Every vaccine goes through a series of studies and clinical trials before being approved by the FDA to ensure safety and effectiveness.1 Vaccines are studied intensively via the FDA, the CDC, and many other organizations to help explore possible complications from vaccines, especially Pfizer, Moderna, and Johnson & Johnson during this pandemic.

To celebrate and learn more about the regulatory pathway of vaccines in the US, please contact EMMA International today at info@emmainternational.com or 248-987-4497.

1NATIONAL IMMUNIZATION AWARENESS MONTH – August. (2020). National Day Calendar. https://nationaldaycalendar.com/national-immunization-awareness-month-august/

‌ 

Abby McVay

Abby McVay

Research Analyst- Ms. McVay is EMMA International’s Research Analyst. She has experience in technical writing and clinical trials in many life science industries. She has experience with many different elements of quality and regulatory compliance. Ms. McVay holds a Bachelor of Science in Psychology from Manchester University as well as a Master of Science in Industrial and Organizational Psychology from Angelo State University.

More Resources

De Novo Classification

De Novo Classification

A device can be registered for the De Novo pathway if there is evidence of the safety and effectiveness of the device and there is not a previously legally marketed predicate device1. When determining if your device can go through the De Novo process there are two pathways available to determine the device classification.
Abbreviated 510k submission

Abbreviated 510k submission

There are three types of 510K, Premarket Notifications, which can be submitted to the Food and Drug Administration (FDA) traditional, abbreviated, and special. Abbreviated and Special 510K submissions can be utilized when the submissions meet the certain factors presented by the FDA. When submitting an abbreviated 510K the submission must include the elements that are identified in 21CFR 807.87 for the information required in a premarket notification submission.
Is your product a medical device?

Is your product a medical device?

Many marketed products are classified as medical devices and you would not even know it. Medical devices range from latex gloves and tongue depressors to respirators and heart valves. To determine if the product is considered a medical device by the Food and Drug Administration (FDA) you will need to analyze if your product meets the definition of a medical device per the Food, Drug, and Cosmetic Act1.

Ready to learn more about working with us?

Pin It on Pinterest

Share This